Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Editas Medicine (EDIT) Notes Payables: 2016-2017

Historic Notes Payables for Editas Medicine (EDIT) over the last 2 years, with Dec 2017 value amounting to $7.5 million.

  • Editas Medicine's Notes Payables fell 25.00% to $7.5 million in Q4 2017 from the same period last year, while for Dec 2017 it was $7.5 million, marking a year-over-year decrease of 25.00%. This contributed to the annual value of $7.5 million for FY2017, which is 25.00% down from last year.
  • According to the latest figures from FY2017, Editas Medicine's Notes Payables is $7.5 million, which was down 25.00% from $10.0 million recorded in FY2016.
  • Over the past 5 years, Editas Medicine's Notes Payables peaked at $10.0 million during FY2016, and registered a low of $7.5 million during FY2017.
  • Over the past 2 years, Editas Medicine's median Notes Payables value was $8.8 million (recorded in 2016), while the average stood at $8.8 million.
  • Data for Editas Medicine's Notes Payables shows a maximum YoY declined of 25.00% (in 2017) over the last 5 years.
  • Over the past 2 years, Editas Medicine's Notes Payables (Yearly) stood at $10.0 million in 2016, then dropped by 25.00% to $7.5 million in 2017.